Gross Margin
10.36%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 8.32%.Updated Aug 22, 2026Profit Margin
-0.65%vs Specialty Chemicals peers Updated Aug 22, 2026Operating Margin
6.91%vs Specialty Chemicals peers Updated Aug 22, 2026Return on Assets (TTM)
-0.12%vs Specialty Chemicals peers Updated Aug 22, 2026Return on Equity (TTM)
-0.39%vs Specialty Chemicals peers Updated Aug 22, 2026Revenue (TTM)
22.83BTHB699.54M · vs all stocks (USD) Updated Aug 22, 2026Revenue per Share (TTM)
8.01THBUpdated Aug 22, 2026Quarterly Revenue Growth
-16.20%vs Specialty Chemicals peers Updated Aug 22, 2026Gross Profit (TTM)
1.90BTHB58.21M · vs all stocks (USD) Updated Aug 22, 2026EBITDA (TTM)
3.17BTHB97.14M · vs all stocks (USD) Updated Aug 22, 2026Net Income (TTM)
-148.75MTHB-4.56M · vs all stocks (USD) Updated Aug 22, 2026Quarterly Earnings Growth (YoY)
-9.50%vs Specialty Chemicals peers Updated Aug 22, 2026Operating Cash Flow (TTM)
3.23BTHB98.88M · vs all stocks (USD) Updated Aug 22, 2026Levered Free Cash Flow (TTM)
2.34BTHB71.73M · vs all stocks (USD) Updated Aug 22, 2026Forward Annual Dividend Rate
1.00THBUpdated Aug 22, 2026Forward Annual Dividend Yield
9.09%Updated Aug 22, 2026Trailing Annual Dividend Rate
1.00THBUpdated Aug 22, 2026Trailing Annual Dividend Yield
9.09%Updated Aug 22, 20265-Year Average Dividend Yield
10.08%Updated Aug 22, 2026Payout Ratio
147.06%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 769.23%.Updated Aug 22, 2026Revenue
23.89BTHBFY2025 · Dec 31, 2025Cost of Goods Sold
21.71BTHBFY2025 · Dec 31, 2025Gross Profit
2.18BTHBFY2025 · Dec 31, 2025Operating Income
460.08MTHB14.10M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-235.38MTHBFY2025 · Dec 31, 2025Income Tax Expense
-126.79MTHBFY2025 · Dec 31, 2025Net Income
-108.59MTHBFY2025 · Dec 31, 2025EBIT
51.87KTHBFY2025 · Dec 31, 2025EBITDA (Income Statement)
3.18BTHBFY2025 · Dec 31, 2025Selling, General & Administrative
1.65BTHBFY2025 · Dec 31, 2025Other Operating Expenses
-83.31MTHBFY2025 · Dec 31, 2025Non-operating Interest Income
166.42MTHBFY2025 · Dec 31, 2025Non-operating Interest Expense
235.43MTHBFY2025 · Dec 31, 2025Operating Cash Flow
3.82BTHBFY2025 · Dec 31, 2025Free Cash Flow
2.96BTHBFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.96BTHBFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-235.38MTHBFY2025 · Dec 31, 2025Depreciation & Amortization
2.40BTHBFY2025 · Dec 31, 2025Other Non-cash Items
468.69MTHBFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
448.05MTHBFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
746.34MTHBFY2025 · Dec 31, 2025Capital Expenditures
-861.24MTHBFY2025 · Dec 31, 2025Net Acquisitions
0.00THBFY2025 · Dec 31, 2025Purchase of Investments
-580.27MTHBFY2025 · Dec 31, 2025Sale of Investments
1.51BTHBFY2025 · Dec 31, 2025Net Investing Cash Flow
68.88MTHBFY2025 · Dec 31, 2025Long-term Debt Issuance
1.88BTHBFY2025 · Dec 31, 2025Long-term Debt Payments
-4.68BTHBFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-2.03BTHBFY2025 · Dec 31, 2025Common Stock Repurchase
-551.09MTHBFY2025 · Dec 31, 2025Common Dividends Paid
-1.43BTHBFY2025 · Dec 31, 2025Net Financing Cash Flow
-6.81BTHBFY2025 · Dec 31, 2025